Literature DB >> 8811015

Expression of muscovy duck parvovirus capsid proteins (VP2 and VP3) in a baculovirus expression system and demonstration of immunity induced by the recombinant proteins.

G Le Gall-Reculé1, V Jestin, P Chagnaud, P Blanchard, A Jestin.   

Abstract

The gene encoding the muscovy duck parvovirus (DPV)-strain 89384 capsid proteins VP2 and VP3 was cloned in a baculovirus expression system and expressed in insect cells. The recombinant proteins were found to react with specific anti-DPV serum by Western blotting and to be located in the nucleus of insect cells (Sf9) as shown by immunofluorescence. Empty virus-like particles (VLPs) identical in size and appearance to DPV virions were observed by electron microscopy. The antigenicity and immunogenicity of the recombinant proteins were evaluated by ELISA and seroneutralization. Immunization of 3-week-old muscovy ducklings induced anti-DPV antibodies; neutralizing antibody titres were consistent with those observed in ducklings inoculated with a commercial inactivated vaccine. The way to develop these promising results is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811015     DOI: 10.1099/0022-1317-77-9-2159

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Visualization of the externalized VP2 N termini of infectious human parvovirus B19.

Authors:  Bärbel Kaufmann; Paul R Chipman; Victor A Kostyuchenko; Susanne Modrow; Michael G Rossmann
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

2.  Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection.

Authors:  Arie Rogel; Luna Benvenisti; Ilan Sela; Orit Edelbaum; Edna Tanne; Yehoshua Shachar; Yehuda Zanberg; Tanya Gontmakher; Eli Khayat; Yehuda Stram
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

3.  Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody.

Authors:  Bärbel Kaufmann; Alberto López-Bueno; Mauricio G Mateu; Paul R Chipman; Christian D S Nelson; Colin R Parrish; José M Almendral; Michael G Rossmann
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

4.  Construction and sequencing of an infectious clone of the goose embryo-adapted Muscovy duck parvovirus vaccine strain FZ91-30.

Authors:  Jianye Wang; Yu Huang; Mingxu Zhou; Philip R Hardwidge; Guoqiang Zhu
Journal:  Virol J       Date:  2016-06-21       Impact factor: 4.099

5.  Specific detection of Muscovy duck parvovirus infection by TaqMan-based real-time PCR assay.

Authors:  Chunhe Wan; Cuiteng Chen; Longfei Cheng; Hongmei Chen; Qiuling Fu; Shaohua Shi; Guanghua Fu; Rongchang Liu; Yu Huang
Journal:  BMC Vet Res       Date:  2018-09-03       Impact factor: 2.741

Review 6.  Vaccines for viral and parasitic diseases produced with baculovirus vectors.

Authors:  Monique M van Oers
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

Review 7.  Virus-like particles: the new frontier of vaccines for animal viral infections.

Authors:  Elisa Crisci; Juan Bárcena; María Montoya
Journal:  Vet Immunol Immunopathol       Date:  2012-06-01       Impact factor: 2.046

8.  Characterization of monoclonal antibodies against waterfowl parvoviruses VP3 protein.

Authors:  Xiuchen Yin; Shumei Zhang; Youlan Gao; Jinzhe Li; Shuyi Tan; Hongyu Liu; Xiaoying Wu; Yuhuan Chen; Ming Liu; Yun Zhang
Journal:  Virol J       Date:  2012-11-23       Impact factor: 4.099

Review 9.  Role of capsid proteins in parvoviruses infection.

Authors:  Mengyu Tu; Fei Liu; Shun Chen; Mingshu Wang; Anchun Cheng
Journal:  Virol J       Date:  2015-08-04       Impact factor: 4.099

10.  A Conserved Epitope Mapped with a Monoclonal Antibody against the VP3 Protein of Goose Parvovirus by Using Peptide Screening and Phage Display Approaches.

Authors:  Chenxi Li; Hongyu Liu; Jinzhe Li; Dafei Liu; Runze Meng; Qingshan Zhang; Wulin Shaozhou; Xiaofei Bai; Tingting Zhang; Ming Liu; Yun Zhang
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.